Antitumor Activity of Isalpinin from Paphiopedilum dianthum on Non-Small Cell Lung Cancer Cell Lines
Molecules · 2025
DOI: 10.3390/molecules30132762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Phisit Pouyfung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Health and Safety, School of Public Health, Walailak University, Nakhon Si Thammarat 80160, Thailand. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Walailak University, School of Engineering and Technology.
Abstract (Originalsprache)
Lung cancer is a leading cause of cancer-related deaths globally, with current treatments having significant limitations, including drug resistance, metastasis, and tumor heterogeneity. This study investigated the anticancer potential of isalpinin, a flavonoid isolated from Paphiopedilum dianthum, against non-small cell lung cancer (NSCLC) cell lines A549, H23, and H460. Isalpinin significantly inhibited NSCLC cell viability in a dose- and time-dependent manner; H23 and H460 cells showed greater sensitivity (IC50 a ~ 44 μM at 48 h) compared to A549 cells (IC50 82 μM). Isalpinin suppressed proliferation, migration, and anchorage-independent growth, particularly in H23/H460 cells. Mechanistically, it induced apoptosis via increased ROS production and Bcl-2 downregulation, particularly in H23 and H460 cells. In a molecular docking analysis, isalpinin was found to directly bind to the ATP-binding pocket of AKT1, as confirmed by reduced Akt/GSK3β phosphorylation. These results suggest that isalpinin showed a potent multi-target natural compound against NSCLC that disrupts the key hallmarks of malignancy and pro-survival signaling. However, its subtype-specific efficacy warrants further in vivo studies and an investigation of combinatorial therapeutic approaches to elucidate its clinical potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational Health and Safety, School of Public Health, Walailak University, Nakhon Si Thammarat 80160, Thailand.
- Biomass and Oil Palm Center of Excellence, Walailak University, Nakhon Si Thammarat 80160, Thailand.
- Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Animal Models of Chronic Inflammation-Associated Diseases for Drug Discovery Research Unit, Chulalongkorn University, Bangkok 10330, Thailand.
- College of Public Health, Kunming Medical University, Kunming 650500, China.
- Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection and Graduate School of Medical Sciences, Kumamoto University, Honjo, Chuou-ku, Kumamoto 860-0811, Japan.
ORCID-Profile: Hua Bai, Achitphol Chookaew, Varisa Pongrakhananon, Piriya Chonsut, Suwichak Chaisit
Förderung
- Walailak University
- School of Engineering and Technology
Zitieren
APA
Pouyfung, P., Lertnitikul, N., Bai, H., Chookaew, A., Pongrakhananon, V., Chonsut, P., & Chaisit, S. (2025). Antitumor Activity of Isalpinin from Paphiopedilum dianthum on Non-Small Cell Lung Cancer Cell Lines. Molecules. https://doi.org/10.3390/molecules30132762
Vancouver
Pouyfung P, Lertnitikul N, Bai H, Chookaew A, Pongrakhananon V, Chonsut P, et al. Antitumor Activity of Isalpinin from Paphiopedilum dianthum on Non-Small Cell Lung Cancer Cell Lines. Molecules. 2025. doi:10.3390/molecules30132762
BibTeX
@article{Pouyfung2025,
author = {Pouyfung, Phisit and Lertnitikul, Nonthalert and Bai, Hua and Chookaew, Achitphol and Pongrakhananon, Varisa and Chonsut, Piriya and Chaisit, Suwichak},
title = {Antitumor Activity of Isalpinin from Paphiopedilum dianthum on Non-Small Cell Lung Cancer Cell Lines},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30132762}
}
EUVIMED